Community-acquired methicillin-resistant Staphylococcus aureus infections in children;Infecciones por Staphylococcus aureus resistente a meticilina adquirido en la comunidad en niños

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 10, 2010, Pages 675-679

  Frick, Marie Antoinette ^a   Moraga Llop, Fernando A ^a   Bartolom, Rosa ^a   Larrosa, Nieves ^a   Campins, Magda ^a   Roman, Yuani ^a   Vindel, Ana ^b   Figueras, Concepci ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antibiotic treatment; Community acquired methicillin resistant Staphylococcus aureus; Methicillin resistant; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; LINCOSAMIDE; MACROLIDE; METICILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN BINDING PROTEIN 2A;

ADOLESCENT; AGAR DIFFUSION; AGAR DISK DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; FAMILY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT OUTCOME;

ABSCESS; ADOLESCENT; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; EMIGRANTS AND IMMIGRANTS; EXOTOXINS; FAMILY HEALTH; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SOFT TISSUE INFECTIONS; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 78649678390     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2010.01.007     Document Type: Article

References (40)

1. E.S. Buescher Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics Curr Opin Pediatr 17 2005 67 70
2. B.C. Herold, L.C. Immergluck, M.C. Maranam, D.S. Lauderdale, R.E. Gaskin, and S. Boyle-Vavra Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk JAMA 279 1998 593 598
3. M.D. King, B.J. Humphrey, Y.F. Wang, E.V. Kourbatova, S.M. Ray, and H.M. Blumberg Emergency of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections Ann Intern Med 144 2006 309 317
4. G.J. Morn, A. Krishnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, and R.B. Carey Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
5. A. Tristan, M. Bes, M. Meugnier, G. Lina, B. Bozdogan, and P. Courvalin Global distribution of Panton-Valentine leukocidin-positive methicillin- resistant Staphylococcus aureus Emerg Infect Dis 13 2007 594 600
6. P. Dufour, Y. Gillet, M. Bes, G. Lina, F. Vandanesch, and D. Floret Community acquired methicillin-resistant Staphylococcus aureus infections in France: Emerge of a single clone that produces Panton-Valentine leukocidin Clin Infect Dis 35 2002 819 824
7. G. Lina, Y. Pimont, F. Godail-Gamot, M. Bes, M.O. Peter, and V. Gauduchon Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia Clin Infect Dis 29 1999 1128 1132
8. J.M. Voyich, M. Otto, B. Mathema, K.R. Braughton, A.R. Whitney, and D. Welty Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194 2006 1761 1770
9. S.L. Kaplan, K.G. Hulten, B.E. Gonzlez, W.A. Hammerman, L. Lamberth, and J. Versalovic Three-year surveillance of community-acquired Staphylococcus aureus infections in children Clin Infect Dis 40 2005 1785 1791
10. X.W. Huijsdens, M.G. Van Santen-Verheuvel, E. Spalburg, M.E. Heck, G.N. Pluister, and B.A. Eijkelkamp Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus J Clin Microbiol 44 2006 2994 2996
11. F. Chaves, M. Daskalaki, and J.R. Otero Epidemiologa de las infecciones por grampositivos multirresistentes Enferm Infecc Microbiol Clin 26 2008 4 12
12. H. Fang, and G. Hedin Rapid screening and identification of methicillin-resistant Staphylococcus aureus from clinical samples by selective broth and real-time PCR assay J Clin Microbiol 41 2003 2894 2899
13. G. Lina, Y. Pimont, G. Godail-Gamot, M. Bes, M.O. Peter, and V. Gauduchon Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia Clin Infect Dis 29 1999 1128 1132
14. M.T.G. Holden, E.J. Feil, J.A. Lindsay, S.J. Peacock, N.P. Day, and M.C. Enright Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance Proc Natl Acad Sci USA 101 2004 9786 9791
15. K. Zhang, J.A. McClure, S. Elsayed, and J.M. Conly Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harbouring class A mec and type 4 ccr gene complexes in Canadian epidemic strain of methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 2009 531 540
16. C. Reinert, J.A. McCulloch, S. Watanabe, T. Ito, K. Hiramatsu, and E.M. Mamizuka Type IV SCCmec found in decade old Brazilian MRSA isolates Braz J Infect Dis 12 2008 213 216
17. A. Broseta, F. Chaves, P. Rojo, and J.R. Otero Emergencia de un clon de Staphylococcus aureus resistente a meticilina de origen comunitario en la poblacin peditrica del sur de Madrid Enferm Infecc Microbiol Clin 24 2006 31 35
18. P. Panton, and F. Valentine Staphylococcal toxins Lancet 222 1932 506 508
19. B. Knig, G. Prvost, Y. Pimont, and W. Knig Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes J Infect Dis 171 1995 607 613
20. C. Von Eiff, A.W. Friedrich, G. Peters, and K. Becker Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus Diagn Microbiol Infect Dis 49 2004 157 162
21. R. Wang, K.R. Braughton, D. Kretschmer, T.H. Bach, S.Y. Queck, and M. Li Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA Nat Med 13 2007 1510 1514
22. K. Boubaker, P. Diebold, D.S. Blanc, F. Vandenesch, G. Praz, and G. Dupuis Panton-valentine leukocidin and staphyloccoccal skin infections in schoolchildren Emerg Infect Dis 10 2004 121 124
23. M. Tobea, F. Coll, C. Garca-Fontecha, R. Bartolom, and F.A. Moraga-Llop Fascitis necrosante por Staphylococcus aureus resistente a la meticilina adquirido en la comunidad productor de leucocidina de Panton-Valentine An Pediatr (Barc) 70 2009 374 378
24. E. Ruiz de Gopegui, A. Oliver, J. Herrero, and J.L. Prez Neumona nosocomial por Staphylococcus aureus resistente a meticilina de origen comunitario productor de leucocidina de Panton-Valentine Enferm Infecc Microbiol Clin 26 2008 531 535
25. A. Luque, A. Durn, A. Bergad, A. Frick, and C. Calls Osteomielitis aguda y neumona comunitaria por Staphylococcus aureus resistente a meticilina An Pediatr (Barc) 68 2008 373 376
26. C. Nourse, M. Starr, and W. Munckhof Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: Literature review and recommendations for management J Paediatr Child Health 43 2007 656 661
27. C. Aspiroz, I. Martn, C. Lozano, and C. Torres Primer caso de meningitis por Staphylococcus aureus resistente a meticilina de origen comunitario ST88 productor de leucocidina de Panton Valentine en España Enferm Infecc Microbiol Clin 28 2010 70 71
28. E.M. D'Agata, G.F. Webb, M.A. Horn, R.C. Moellering Jr, and S. Ruan Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals Clin Infect Dis 48 2009 274 284
29. J.G. Gordon, and F.D. Lowy Pathogenesis of methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 46 2008 350 359
30. G.L. Archer Staphylococcus aureus: A well-armed pathogen Clin Infect Dis 26 1998 1179 1181
31. Centers for Disease Control Prevention (CDC) Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 20002003 MMWR 52 2003 793 795
32. C.E. Zinderman, B. Conner, M.A. Malakooti, J.E. LaMar, A. Armstrong, and B.K. Bohnker Community-acquired methicillin-resistant Staphylococcus aureus among military recruits Emerg Infect Dis 10 2004 941 944
33. Centers for Disease Control Prevention (CDC) Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in state prisonMississippi, 2000 MMWR 50 2001 919 922
34. A. Molinos, L. Marcos, A. Porras, E. Peromingo, and I. Obando Infeccin por Staphylococcus aureus resistente a meticilina de origen comunitario con transmisin intrafamiliar An Pediatr (Barc) 69 2008 577 592
35. J. Rodrguez-Bao, C. Bischofberger, F. lvarez-Lerma,. Asensio, T. Delgado, and D. Garca-Arcal Vigilancia y control de Staphylococcus aureus resistente a meticilina en hospitales espaoles. Documento de consenso GEIH-SEIMC y SEMPSPH Enferm Infecc Microbiol Clin 26 2008 285 298
36. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare. [consultado 30/5/2009]. Disponible en: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf.
37. C.G. Gemmell, D.I. Edwards, A.P. Fraise, F.K. Gould, G.L. Ridgway, and R.E. Warren Guidelines for the prophylaxis and treatment of methicillin- resistant Staphylococcus aureus (MRSA) infections in the UK J Antimicrob Chemother 57 2006 589 608
38. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. [consultado 30/5/2009]. Disponible en: http://www.cdc.gov/ncidod/dhqp/ar-mrsa- ca.html.
39. R.C. Moellering Jr Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection Clin Infect Dis 46 2008 1032 1037
40. S.J. Rehm Staphylococcus aureus: The new adventures of a legendary pathogen Cleve Clin J Med 75 2008 177 180 1836, 1902